Effect of Thyroid Hormone on Post-Myocardial Infarction Remodeling and Prognosis in STEMI Patients

NCT ID: NCT03933358

Last Updated: 2019-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-01

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to determine whether thyroid hormone levels are predictive of cardiac remodeling following myocardial infarction and the prognosis in patients with STEMI receiving primary percutaneous coronary intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thyroid Cardiac Remodeling, Ventricular STEMI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Euthyroid

Thyroid hormone levels

Intervention Type OTHER

This is an observational study. Exposure: Different thyroid hormone levels.

Low T3

low triiodothyronine syndrome

Thyroid hormone levels

Intervention Type OTHER

This is an observational study. Exposure: Different thyroid hormone levels.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thyroid hormone levels

This is an observational study. Exposure: Different thyroid hormone levels.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* with a confirmed STEMI diagnosis
* undergoing primary percutaneous coronary intervention (presenting \<12h after symptom onset)
* patients agreed and provided informed consent

Exclusion Criteria

* past history of myocardial infarction or percutaneous coronary intervention or coronary artery bypass graft
* past history of heart failure (LVEF\<40%) or myocardiopathy or atrial fibrillation
* past history of thyroid diseases, or were treated with amiodarone, dopamine, or corticosteroids before hospital admission
* contraindicating to cardiac magnetic resonance imaging
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Friendship Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hongwei Li, MD

Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Friendship Hospital, Capital Medical University

Beijing, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hongwei Li

Role: CONTACT

0086 10 63139780

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wen Su

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BFH-Thyroid and STEMI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.